The merger of 'sanofi-aventis' as an example for Reasons and Consequences of Mergers and Acquistions in the Pharmaceutical Industry

Business & Finance, Marketing & Sales
Cover of the book The merger of 'sanofi-aventis' as an example for Reasons and Consequences of Mergers and Acquistions in the Pharmaceutical Industry by Martin Wenderoth, GRIN Verlag
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: Martin Wenderoth ISBN: 9783640267033
Publisher: GRIN Verlag Publication: February 13, 2009
Imprint: GRIN Verlag Language: English
Author: Martin Wenderoth
ISBN: 9783640267033
Publisher: GRIN Verlag
Publication: February 13, 2009
Imprint: GRIN Verlag
Language: English

Essay from the year 2008 in the subject Business economics - Marketing, Corporate Communication, CRM, Market Research, Social Media, grade: (4) good, Eötvös Loránd Tudományegytem (International PhD Program), course: Business Economics, 22 entries in the bibliography, language: English, abstract: Within the ongoing globalisation process, many national markets and industrial branches are in different phases of the transition from local to global economic structures (Bryan, L.; Fraser, J.; Oppenheim, J. Rall, W., 2000, pp. 71-95). As a result of this development organisations in the different industries are increasingly concentrating (Brühl, V., 2003, pp. 274-278). Among other industries, also the pharmaceutical industry is highly influenced by the above mentioned trend, reflected by the increasing number of mergers and acquisitions (M&A's) in the pharmaceutical industry, which is illustrated in the following figure. Figure 1: The present assignment is going to evaluate the reasons and consequences of M&A's within the pharmaceutical industry by using the sanofi-aventis merger as an example. First of all, the recent history of sanofi-aventis is briefly described. The third part will describe the reasons and consequences of mergers and acquisitions in the pharmaceutical industry by describing the challenges the pharmaceutical branch is confronted with and the respective motives of and results from M&A activities. Finally, the major findings are summarised and conclusions will be derived. 2. History of sanofi-aventis Following the company homepage of sanofi-aventis (20071), the year 1999 has been very im-portant because of two reasons. First of all, Sanofi took over the Synthelabo Holding GmbH and changed its company name to Sanofi-Synthelabo. Furthermore, Hoechst merged with Rhône-Poulenc, a French chemical and pharmaceutical organisation in order to form the new company Aventis, with its legal seat in Strassbourgh (...)

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Essay from the year 2008 in the subject Business economics - Marketing, Corporate Communication, CRM, Market Research, Social Media, grade: (4) good, Eötvös Loránd Tudományegytem (International PhD Program), course: Business Economics, 22 entries in the bibliography, language: English, abstract: Within the ongoing globalisation process, many national markets and industrial branches are in different phases of the transition from local to global economic structures (Bryan, L.; Fraser, J.; Oppenheim, J. Rall, W., 2000, pp. 71-95). As a result of this development organisations in the different industries are increasingly concentrating (Brühl, V., 2003, pp. 274-278). Among other industries, also the pharmaceutical industry is highly influenced by the above mentioned trend, reflected by the increasing number of mergers and acquisitions (M&A's) in the pharmaceutical industry, which is illustrated in the following figure. Figure 1: The present assignment is going to evaluate the reasons and consequences of M&A's within the pharmaceutical industry by using the sanofi-aventis merger as an example. First of all, the recent history of sanofi-aventis is briefly described. The third part will describe the reasons and consequences of mergers and acquisitions in the pharmaceutical industry by describing the challenges the pharmaceutical branch is confronted with and the respective motives of and results from M&A activities. Finally, the major findings are summarised and conclusions will be derived. 2. History of sanofi-aventis Following the company homepage of sanofi-aventis (20071), the year 1999 has been very im-portant because of two reasons. First of all, Sanofi took over the Synthelabo Holding GmbH and changed its company name to Sanofi-Synthelabo. Furthermore, Hoechst merged with Rhône-Poulenc, a French chemical and pharmaceutical organisation in order to form the new company Aventis, with its legal seat in Strassbourgh (...)

More books from GRIN Verlag

Cover of the book Fair value measurement by Martin Wenderoth
Cover of the book Seelsorge an der eigenen Seele by Martin Wenderoth
Cover of the book Normales Altern unnormal? Menschen mit geistiger Behinderung im Ruhestand by Martin Wenderoth
Cover of the book Unleashing VoLTE capabilities. Assessing the Migration from CS Voice to IMS-based Voice over LTE (VoLTE) by Martin Wenderoth
Cover of the book Deutsches Apothekenrecht zum Fremd- und Mehrbesitzverbot im Kontext der europäischen Gesetzgebung by Martin Wenderoth
Cover of the book PIS - Personalinformationssysteme by Martin Wenderoth
Cover of the book Usability und Design - Gegenüberstellung zweier Ansätze der Webseitengestaltung by Martin Wenderoth
Cover of the book Die Musik von '21 Grams': Minimalistische Filmmusik mit hohem Wirkungsgrad by Martin Wenderoth
Cover of the book Management und Zielkonflikte in Nationalparks im internationalen Vergleich by Martin Wenderoth
Cover of the book Die Subjektivierung der Arbeit und die Krise der bundesdeutschen Gewerkschaften by Martin Wenderoth
Cover of the book Trainingssteuerung im Sportschwimmen by Martin Wenderoth
Cover of the book Entwicklungszusammenarbeit in Burkina Faso by Martin Wenderoth
Cover of the book Kritische Auseinandersetzung mit Jane Elliotts Anti-Rassismus-Training 'blue-eyed/ brown-eyed' by Martin Wenderoth
Cover of the book Where We Belong To by Martin Wenderoth
Cover of the book Bankenregulierung: Ursachen, Ziele und Formen by Martin Wenderoth
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy